At the time of writing, Abbvie Inc [ABBV] stock is trading at $200.88, up 1.79%. An important factor to consider is whether the stock is rising or falling in short-term value. The ABBV shares have gain 4.08% over the last week, with a monthly amount glided 16.38%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Daiwa Securities downgraded its rating to Neutral on December 05, 2024, and kept the price target unchanged to $180. On November 22, 2024, upgrade upgraded it’s rating to Outperform but maintained its price target of $206 on the stock. Wolfe Research started tracking the stock assigning a Outperform rating and suggested a price target of $205 on November 15, 2024. Argus upgraded its rating to a Buy. Bernstein started tracking with a Mkt Perform rating for this stock on October 17, 2024, and assigned it a price target of $203. In a note dated June 05, 2024, HSBC Securities upgraded an Buy rating on this stock but restated the target price of $185.
For the past year, the stock price of Abbvie Inc fluctuated between $153.58 and $207.32. Currently, Wall Street analysts expect the stock to reach $214.8 within the next 12 months. Abbvie Inc [NYSE: ABBV] shares were valued at $200.88 at the most recent close of the market. An investor can expect a potential return of 6.93% based on the average ABBV price forecast.
Analyzing the ABBV fundamentals
According to Abbvie Inc [NYSE:ABBV], the company’s sales were 56.33B for trailing twelve months, which represents an 5.60% jump. Gross Profit Margin for this corporation currently stands at 0.74% with Operating Profit Margin at 0.16%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.71 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of20.19.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 198.02 points at the first support level, and at 195.16 for the second support level. However, for the 1st resistance point, the stock is sitting at 202.55, and for the 2nd resistance point, it is at 204.22.
Ratios To Look Out For
It is important to note that Abbvie Inc [NYSE:ABBV] has a current ratio of 0.66. On the other hand, the Quick Ratio is 0.55, and the Cash Ratio is 0.14. Considering the valuation of this stock, the price to sales ratio is 6.30, the price to book ratio is 106.65 and price to earnings (TTM) ratio is 83.99.
Transactions by insiders
Recent insider trading involved PERRY C SIATIS, Officer, that happened on Feb 20 ’25 when 5778.0 shares were purchased. SVP, CONTROLLER, Buckbee Kevin K completed a deal on Dec 16 ’24 to sell 1800.0 shares. Meanwhile, Officer Buckbee Kevin K bought 1800.0 shares on Dec 16 ’24.
